Improved repair of rabbit calvarial defects with hydroxyapatite/chitosan/polycaprolactone composite scaffold-engrafted EPCs and BMSCs

Endothelial progenitor cells (EPCs) expressing vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) and bone marrow mesenchymal stem cells (BMSCs) expressing endogenous bone morphogenetic protein-2 (BMP-2) play the important role in new bone formation. This study investigated the effects of a porous hydroxyapatite (HA)/chitosan (CS)/polycaprolactone (PCL) composite scaffold-engrafted EPCs and BMSCs on the expression of BMP-2, VEGF, and PDGF in the calvarial defect rabbit model in vivo. It showed that a three-dimensional composite scaffold was successfully constructed by physical interaction with a pore size of 250 μm. The HA/CS/PCL scaffold degraded slowly within 10 weeks and showed non-cytotoxicity. By X-ray, micro-CT examination, and H&E staining, compared with the HA/CS/PCL group, HA/CS/PCL + EPCs, HA/CS/PCL + BMSCs, and HA/CS/PCL + EPCs + BMSCs groups performed a more obvious repair effect, and the dual factor group presented particularly significant improvement on the percentages of bone volume at week 4 and week 8, with evident bone growth. Osteogenesis marker (BMP-2) and vascularization marker (VEGF and PDGF) expression in the dual factor group were much better than those of the HA/CS/PCL control group and single factor groups. Collectively, the HA/CS/PCL composite scaffold-engrafting EPCs and BMSCs is effective to repair calvarial defects by regulating endogenous expression of BMP-2, VEGF, and PDGF. Thus, this study provides important implications for the potential clinical application of biomaterial composite scaffold-engrafted engineering cells.

[1]  Jincheng Wang,et al.  Chitosan-Based Biomaterial Scaffolds for the Repair of Infected Bone Defects , 2022, Frontiers in Bioengineering and Biotechnology.

[2]  Y. Huang,et al.  Shensu IV prevents glomerular podocyte injury in nephrotic rats via promoting lncRNA H19/DIRAS3-mediated autophagy , 2021, Bioscience reports.

[3]  Xiazhou Fu,et al.  Sulforaphane Inhibits Osteoclastogenesis via Suppression of the Autophagic Pathway , 2021, Molecules.

[4]  张 丽 夏凌云 毛 敏 倪小兵 冷卫东 罗 杰 余和东.  3D打印成型纳米羟基磷灰石/壳聚糖/聚己内酯三元复合支架材料的构建及表征 , 2020 .

[5]  Peng Ding,et al.  Impairment of circulating endothelial progenitor cells (EPCs) in patients with glucocorticoid-induced avascular necrosis of the femoral head and changes of EPCs after glucocorticoid treatment in vitro , 2019, Journal of Orthopaedic Surgery and Research.

[6]  Tong Wang,et al.  Catalpol Promotes the Survival and VEGF Secretion of Bone Marrow-Derived Stem Cells and Their Role in Myocardial Repair After Myocardial Infarction in Rats , 2018, Cardiovascular Toxicology.

[7]  P. M. Menon,et al.  BMP2 expressing genetically engineered mesenchymal stem cells on composite fibrous scaffolds for enhanced bone regeneration in segmental defects. , 2018, Materials science & engineering. C, Materials for biological applications.

[8]  Yong Gu,et al.  Controlled release of BMP-2 from a collagen-mimetic peptide-modified silk fibroin-nanohydroxyapatite scaffold for bone regeneration. , 2017, Journal of materials chemistry. B.

[9]  U. Sezerman,et al.  Expression of the Bone Morphogenetic Protein-2 (BMP2) in the Human Cumulus Cells as a Biomarker of Oocytes and Embryo Quality , 2017, Journal of human reproductive sciences.

[10]  E. Piva,et al.  Histological Evaluation of Bone Repair with Hydroxyapatite: A Systematic Review , 2017, Calcified Tissue International.

[11]  C. Zhang,et al.  MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1 , 2017, Oncotarget.

[12]  Xiaojuan He,et al.  Increased PLEKHO1 within osteoblasts suppresses Smad‐dependent BMP signaling to inhibit bone formation during aging , 2017, Aging cell.

[13]  A. Salem,et al.  A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9 , 2017, The AAPS Journal.

[14]  A. Mansur,et al.  Glycol chitosan/nanohydroxyapatite biocomposites for potential bone tissue engineering and regenerative medicine. , 2016, International journal of biological macromolecules.

[15]  Su A Park,et al.  Surface modification of 3D-printed porous scaffolds via mussel-inspired polydopamine and effective immobilization of rhBMP-2 to promote osteogenic differentiation for bone tissue engineering. , 2016, Acta biomaterialia.

[16]  M. Prabhakaran,et al.  Elastic poly(ε-caprolactone)-polydimethylsiloxane copolymer fibers with shape memory effect for bone tissue engineering , 2016, Biomedical materials.

[17]  G. Finkenzeller,et al.  Endothelial progenitor cells from peripheral blood support bone regeneration by provoking an angiogenic response. , 2015, Microvascular research.

[18]  Zhicheng Zhang,et al.  One-pot synthesis of carbon coated Fe3O4 nanosheets with superior lithium storage capability , 2015 .

[19]  G. Warnock,et al.  Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration , 2014, OncoTargets and therapy.

[20]  Zhimin Zhu,et al.  Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects. , 2013, Biomaterials.

[21]  Ali Khademhosseini,et al.  Vascularized bone tissue engineering: approaches for potential improvement. , 2012, Tissue engineering. Part B, Reviews.

[22]  Stephen M Warren,et al.  Bone tissue engineering: current strategies and techniques--part I: Scaffolds. , 2012, Tissue engineering. Part B, Reviews.

[23]  David L Kaplan,et al.  The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. , 2011, Biomaterials.

[24]  D. Xue,et al.  Reconstruction of rat calvarial defects with human mesenchymal stem cells and osteoblast-like cells in poly-lactic-co-glycolic acid scaffolds. , 2010, European cells & materials.

[25]  P. Kasten,et al.  Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. , 2010, Acta biomaterialia.

[26]  Michael J Yaszemski,et al.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.

[27]  B. Baroli.  From natural bone grafts to tissue engineering therapeutics: Brainstorming on pharmaceutical formulative requirements and challenges. , 2009, Journal of pharmaceutical sciences.

[28]  David L Kaplan,et al.  Electrospun silk-BMP-2 scaffolds for bone tissue engineering. , 2006, Biomaterials.

[29]  G. Thurston.  Complementary actions of VEGF and Angiopoietin‐1 on blood vessel growth and leakage * , 2002, Journal of anatomy.

[30]  Xuebin B. Yang,et al.  Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. , 2002, Biochemical and biophysical research communications.

[31]  V. Rosen,et al.  Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. , 1996, Biochemical and biophysical research communications.

[32]  C. R. Howlett,et al.  Effect of platelet-derived growth factor on tibial osteotomies in rabbits. , 1994, Bone.

[33]  Zhanghua Li,et al.  Effects of altered CXCL12/CXCR4 axis on BMP2/Smad/Runx2/Osterix axis and osteogenic gene expressions during osteogenic differentiation of MSCs. , 2017, American journal of translational research.

[34]  Geert Carmeliet,et al.  Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. , 2015, Bone.

[35]  Changsheng Liu,et al.  Enhanced healing of rat calvarial defects with sulfated chitosan-coated calcium-deficient hydroxyapatite/bone morphogenetic protein 2 scaffolds. , 2012, Tissue engineering. Part A.

[36]  Shohei Kasugai,et al.  Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. , 2008, Journal of pharmacological sciences.